The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Open accessAbstract
Tissue stromal cells interact with leukaemia cells and profoundly affect their viability and drug sensitivity. Here we show a biochemical mechanism by which bone marrow stromal cells modulate the redox status of chronic lymphocytic leukaemia (CLL) cells and promote cellular survival and drug resistance. Primary CLL cells from patients exhibit a limited ability to transport cystine for glutathione (GSH) synthesis owing to a low expression level of Xc-transporter. In contrast, bone marrow stromal cells effectively import cystine and convert it to cysteine, which is then released into the microenvironment for uptake by CLL cells to promote GSH synthesis. The elevated level of GSH enhances leukaemia cell survival and protects them from drug-induced cytotoxicity. Furthermore, disabling this protective mechanism significantly sensitizes CLL cells to drug treatment in the stromal environment. This stromal–leukaemia interaction is critical for CLL cell survival and represents a key biochemical pathway for effectively targeting leukaemia cells to overcome drug resistance in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Regulation of glutathione synthesis
Lu, S. C. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.005 · Cited by 2,116
Chiorazzi, N., Rai, K. R., & Ferrarini, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041720 · Cited by 1,296
Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.009 · Cited by 1,080
Glutathione-Associated Enzymes In Anticancer Drug Resistance
Tew, K. D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3143 · Cited by 856
Gout, P., Buckley, A., Simms, C., & Bruchovsky, N. (2001) · Leukemia · doi:10.1038/sj.leu.2402238 · Cited by 640
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2010) · Nature · doi:10.1038/nature09132 · Cited by 613
Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.8.2655 · Cited by 607
Self-citationHuman chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
Bichi, R., Shinton, S. A., Martin, E. S., Koval, A., Calin, G. A., Cesari, R., Russo, G., Hardy, R. R., & Croce, C. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102181599 · Cited by 582
Self-citationInhibition of Mitochondrial Respiration
Pelicano, H., Feng, L., Zhou, Y., Carew, J. S., Hileman, E. O., Plunkett, W., Keating, M. J., & Huang, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301546200 · Cited by 495
Self-citationAnalysis of the Adult Human Plasma Metabolome
Lawton, K. A., Berger, A., Mitchell, M., Milgram, K. E., Evans, A. M., Guo, L., Hanson, R. W., Kalhan, S. C., Ryals, J. A., & Milburn, M. V. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.4.383 · Cited by 490
Clinical pharmacokinetics of oxaliplatin: a critical review.
Graham, M. A., Lockwood, G. F., Greenslade, D., Brienza, S., Bayssas, M., & Gamelin, E. (2000) · PubMed · Cited by 455
Redox imbalance in cystine/glutamate transporter-deficient mice
Sato, H., Shiiya, A., Kimata, M., Maebara, K., Tamba, M., Sakakura, Y., Makino, N., Sugiyama, F., Yagami, K.-I., Moriguchi, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506439200 · Cited by 422
Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C., & Stryckmans, P. (1998) · Blood · doi:10.1182/blood.v91.7.2387 · Cited by 413
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
Lo, M., Wang, Y., & Gout, P. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21366 · Cited by 399
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity
Hileman, E. O., Liu, J., Albitar, M., Keating, M. J., & Huang, P. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0726-5 · Cited by 398
Self-citationAmino acid transporters: roles in amino acid sensing and signalling in animal cells
HYDE, R., TAYLOR, P. M., & HUNDAL, H. S. (2003) · Biochemical Journal · doi:10.1042/bj20030405 · Cited by 370
Roecklein, B., & Torok-Storb, B. (1995) · Blood · doi:10.1182/blood.v85.4.997.bloodjournal854997 · Cited by 345
Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G., & Sarfati, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1319 · Cited by 344
Measuring the poise of thiol/disulfide couples in vivo
Jones, D. P., & Liang, Y. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.08.021 · Cited by 340
Cystine-Glutamate Transporter SLC7A11 in Cancer Chemosensitivity and Chemoresistance
Huang, Y., Dai, Z., Barbacioru, C., & Sadée, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4267 · Cited by 340
Transport of cystine and cysteine in mammalian cells
Bannai, S. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(84)90014-5 · Cited by 329
Zhou, Y., Hileman, E. O., Plunkett, W., Keating, M. J., & Huang, P. (2003) · Blood · doi:10.1182/blood-2002-08-2512 · Cited by 327
Self-citationKurtova, A. V., Balakrishnan, K., Chen, R., Ding, W., Schnabl, S., Quiroga, M. P., Sivina, M., Wierda, W. G., Estrov, Z., Keating, M. J., et al. (2009) · Blood · doi:10.1182/blood-2009-07-233718 · Cited by 319
Self-citationZenz, T., Häbe, S., Denzel, T., Mohr, J., Winkler, D., Bühler, A., Sarno, A., Groner, S., Mertens, D., Busch, R., et al. (2009) · Blood · doi:10.1182/blood-2009-05-224071 · Cited by 285
Franco, R., Panayiotidis, M. I., & Cidlowski, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703091200 · Cited by 272
Collins, R. J., Verschuer, L. A., Harmon, B. V., Prentice, R. L., Pope, J. H., & Kerr, J. F. R. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb04290.x · Cited by 253
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.
Buschle, M., Campana, D., Carding, S. R., Richard, C., Hoffbrand, A. V., & Brenner, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.213 · Cited by 248
Regulation of glutathione synthesis
(2001) · Current Topics in Cellular Regulation · doi:10.1016/s0070-2137(01)80004-2 · Cited by 238
Endo, T., Nishio, M., Enzler, T., Cottam, H. B., Fukuda, T., James, D. F., Karin, M., & Kipps, T. J. (2007) · Blood · doi:10.1182/blood-2006-06-027755 · Cited by 221
Haslinger, C., Schweifer, N., Stilgenbauer, S., Döhner, H., Lichter, P., Kraut, N., Stratowa, C., & Abseher, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.133 · Cited by 221
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
Trachootham, D., Zhang, H., Zhang, W., Feng, L., Du, M., Zhou, Y., Chen, Z., Pelicano, H., Plunkett, W., Wierda, W. G., et al. (2008) · Blood · doi:10.1182/blood-2008-04-149815 · Cited by 203
Self-citationChronic lymphocytic leukemia: staging and prognostic factors.
Brugger, W., Fetscher, S., Hasse, J., Frommhold, H., Pressler, K., Mertelsmann, R., Engelhardt, R., & Kanz, L. (1998) · PubMed · Cited by 193
Okuno, S., Sato, H., Kuriyama-Matsumura, K., Tamba, M., Wang, H., Sohda, S., Hamada, H., Yoshikawa, H., Kondo, T., & Bannai, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600786 · Cited by 191
Plasma cysteine, cystine, and glutathione in cirrhosis
Chawla, R. K., Lewis, F. W., Kutner, M. H., Bate, D. M., Roy, R. G. B., & Rudman, D. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90069-6 · Cited by 183
Carew, J. S., Zhou, Y., Albitar, M., Carew, J. D., Keating, M. J., & Huang, P. (2003) · Leukemia · doi:10.1038/sj.leu.2403043 · Cited by 174
Self-citationKönig, A., Menzel, T., Lynen, S., Wrazel, L., Rosén, A., Al-Katib, A., Raveche, E., & Gabrilove, J. (1997) · Leukemia · doi:10.1038/sj.leu.2400556 · Cited by 174
Molecular biology of chronic lymphocytic leukemia.
Reed, J. (1998) · PubMed · Cited by 160
Microenvironmental Interactions and Survival of CLL B-cells
Pedersen, I. M., & Reed, J. C. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190412331272703 · Cited by 143
Kawano, Y., Kobune, M., Yamaguchi, M., Nakamura, K., Ito, Y., Sasaki, K., Takahashi, S., Nakamura, T., Chiba, H., Sato, T., et al. (2002) · Blood · doi:10.1182/blood-2002-04-1268 · Cited by 137
Biology and Treatment of Chronic Lymphocytic Leukemia
Keating, M. J., Chiorazzi, N., Messmer, B. T., Damle, R. N., Allen, S. L., Rai, K. R., Ferrarini, M., & Kipps, T. J. (2003) · Hematology · doi:10.1182/asheducation-2003.1.153 · Cited by 131
Self-citationAntioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic lerkenia
Oltra, A. M., Carbonell, F., Tormos, C., Iradi, A., & Sáez, G. T. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00521-4 · Cited by 127
Hegde, G. V., Peterson, K. J., Emanuel, K. M., Mittal, A. K., Joshi, A. D., Dickinson, J. D., Kollessery, G. J., Bociek, R. G., Bierman, P. J., Vose, J. M., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0142 · Cited by 118
Jewell, A. P., Worman, C. P., Lydyard, P. M., Yong, K., Giles, F. J., & Goldstone, A. H. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb05017.x · Cited by 109
Huang, P., Sandoval, A., Neste, E. V. D., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401845 · Cited by 91
Self-citationFranco, R., DeHaven, W. I., Sifre, M. I., Bortner, C. D., & Cidlowski, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807061200 · Cited by 71
Cystine requirement of continuous human lymphoid cell lines of normal and leukemic origin
Iglehart, J. K., York, R. M., Modest, A. P., Lazarus, H., & Livingston, D. M. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66953-x · Cited by 62
Glutathione depletion in chronic lymphocytic leukemia B lymphocytes
Silber, R., Farber, C., Papadopoulos, E., Nevrla, D., Liebes, L., Bruck, M., Brown, R., & Canellakis, Z. (1992) · Blood · doi:10.1182/blood.v80.8.2038.2038 · Cited by 60
Determining the Clinical Course and Outcome in Chronic Lymphocytic Leukemia
Rai, K. R., & Chiorazzi, N. (2003) · New England Journal of Medicine · doi:10.1056/nejme030032 · Cited by 48
Liu, R., Blower, P. E., Pham, A., Fang, J., Dai, Z., Wise, C., Green, B., Teitel, C. H., Ning, B., Ling, W., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039644 · Cited by 46
Moufarij, M. A., Sampath, D., Keating, M. J., & Plunkett, W. K. (2006) · Blood · doi:10.1182/blood-2006-05-023259 · Cited by 45
Self-citationInfluence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro
Grdiša, M. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00028-6 · Cited by 45
L-cyst(e)ine requirements of malignant cells and progress toward depletion therapy.
Uren, J. R., & Lazarus, H. (1979) · PubMed · Cited by 27
Membranous osteogenesis system modeled with KUSA-A1 mature osteoblasts
Matsumoto, S., Shibuya, I., Kusakari, S., Segawa, K., Uyama, T., Shimada, A., & Umezawa, A. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.05.027 · Cited by 21
Woodlock, T. J., Brown, R., Mani, M., Pompeo, L., Hoffman, H., Segel, G. B., & Silber, R. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450205 · Cited by 15
Cited by
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Koppula, P., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-020-00789-5 · Cited by 2,487
Understanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Zhang, Y., Shi, J., Liu, X., Feng, L., Gong, Z., Koppula, P., Sirohi, K., Li, X., Wei, Y., Lee, H., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0178-0 · Cited by 1,013
Self-citationHow cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 929
Metadata
- Authors
- Zhang, W., Trachootham, D., Liu, J., Chen, G., Pelicano, H., Garcia-Prieto, C., Lu, W., Burger, J. A., Croce, C. M., Plunkett, W., Keating, M. J., & Huang, P.
- Venue
- Nature Cell Biology
- Published
- 2012-02-19
- Volume
- 14
- Issue
- 3
- Pages
- 276-286
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2058376258
- Cited by
- 357
- References
- 57
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.